Tammy Furlong

Insider Reports History

Entity
Individual
Location
C/O Elevation Oncology, Inc., 888 Seventh Avenue, 12 Th Floor, New York, NY
Signature
/s/ Robert Yang, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tammy Furlong:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Elevation Oncology, Inc. CHIEF FINANCIAL OFFICER Restricted Stock Unit 3.3K $14.5K $4.39 May 15, 2024 Direct
Elevation Oncology, Inc. CHIEF FINANCIAL OFFICER Restricted Stock Unit 2.7K $1.65K $0.61 Nov 15, 2024 Direct
Elevation Oncology, Inc. CHIEF FINANCIAL OFFICER Common Stock 1.41K $749 $0.53 Nov 15, 2024 Direct
Elevation Oncology, Inc. CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 225K Feb 15, 2024 Direct

Insider Reports Filed by Tammy Furlong

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELEV Elevation Oncology, Inc. Nov 15, 2024 3 -$52 4 Nov 19, 2024 CHIEF FINANCIAL OFFICER
ELEV Elevation Oncology, Inc. Aug 15, 2024 3 -$64 4 Aug 19, 2024 CHIEF FINANCIAL OFFICER
ELEV Elevation Oncology, Inc. May 15, 2024 3 -$373 4 May 17, 2024 CHIEF FINANCIAL OFFICER
ELEV Elevation Oncology, Inc. Feb 15, 2024 5 -$1.12K 4 Feb 20, 2024 CHIEF FINANCIAL OFFICER
ELEV Elevation Oncology, Inc. Jul 12, 2023 1 $0 4 Jul 14, 2023 CHIEF FINANCIAL OFFICER
ELEV Elevation Oncology, Inc. Jul 12, 2023 0 $0 3 Jul 14, 2023 CHIEF FINANCIAL OFFICER